About: NanOlogy
Profile:
Posts by NanOlogy:
- NanOlogy Announces Two Abstracts Have Been Accepted for Presentation at AACR Special Conference in Cancer Research: Pancreatic Cancer (September 12, 2023 - Home Page, NanOlogy Press Release)
- Cancers: The Role of Therapeutic Endoscopic Ultrasound in Pancreatic Cancer: An Endoscopic Oncologists Perspective (June 28, 2023 - Publications)
- ASCO 2023 Abstract: Safety of locally administered large surface area microparticle paclitaxel and docetaxel in combination with standard of care cancer therapies (June 8, 2023 - Presentations)
- NanOlogy Presents Clinical Research at 2023 DDW and ASCO Involving its Large Surface Area Microparticle Investigational Drugs (June 7, 2023 - Home Page, NanOlogy Press Release)
- DDW 2023 Poster: Intracystic Injection of Large Surface Area Microparticle Paclitael for Chemoablation of Intraductal Papillary Mucinous Neoplasms: Insights from an Expanded Access Protocol (May 25, 2023 - Presentations)
- September 27-30: AACR Special Conference: Pancreatic Cancer | Boston (April 10, 2023 - NanOlogy Events)
- November 1-5: SITC – 38th Annual Meeting Society for Immunotherapy of Cancer | San Diego (April 10, 2023 - NanOlogy Events)
- December 1-3: IASLC 2023 – North American Conference on Lung Cancer| Chicago (April 10, 2023 - NanOlogy Events)
- Diagnostics: A Review of Endoscopic Ultrasound-Guided Chemoablative Techniques for Pancreatic Cystic Lesions (March 23, 2023 - Publications)
- NanOlogy Granted a US Patent for Its Investigational Drugs in Combination with Immune Checkpoint Inhibitors in the Treatment of Cancer (March 7, 2023 - Home Page, NanOlogy Press Release)
- NanOlogy General Presentation (January 2023) (January 6, 2023 - Presentations)
- NanOlogy Publishes Results From a Clinical Trial of Intracystic LSAM-PTX in Mucinous Pancreatic Cysts (December 20, 2022 - NanOlogy Press Release)
- Endosc Int Open: Early phase trial of intracystic injection of large surface area microparticle paclitaxel for treatment of mucinous pancreatic cystsEarly phase trial of intracystic injection of large surface area microparticle paclitaxel for treatment of mucinous pancreatic cysts (December 15, 2022 - Publications)
- NanOlogy Completes Enrollment in Phase 2a Trial of Intratumoral LSAM-PTX with SOC in Patients with Nonoperable Lung Cancer (November 11, 2022 - Home Page, NanOlogy Press Release)
- NanOlogy Publishes Review Article of Preclinical and Clinical Research Supporting LSAM-DTX (September 20, 2022 - Home Page, NanOlogy Press Release)
- Drug Delivery and Translational Research: Local Administration of Large Surface Area Microparticle Docetaxel to Solid Carcinomas Induces Direct Cytotoxicity and Immune-mediated Tumoricidal Effects: Preclinical and Clinical Studies (September 6, 2022 - Publications)
- DDW 2022 Poster: The Efficacy of Intracystic Injection of Large Surface Area Microparticle Paclitaxel (NanoPac®) in the Management of Intraductal Papillary Mucinous Neoplasms: Results from an Expanded Access Protocol (August 6, 2022 - Presentations)
- NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of Large Surface Area Microparticle Docetaxel in High-Risk Non-Muscle Invasive Bladder Cancer (August 1, 2022 - Home Page, NanOlogy Press Release)
